Quality of life and clinical characterization of patients with vernal keratoconjunctivitis in a pediatric population in Colombia
Main Article Content
Keywords
Quality of life, Allergy, Vernal keratoconjunctivitis, Pediatrics
Abstract
Vernal keratoconjunctivitis is one of the most serious ocular allergies that have the potential to induce large ocular morbidity and significant visual changes affecting the quality of life of these individuals.
Methodology: This study was conducted in two phases. The first phase consisted of the clinical characterization of 32 patients from the Clinical Allergology center of the I.P.S. Universitaria from July 2014 to February 2015. A retrospective analysis of medical records was performed.
In the second phase, the evaluation of quality of life was conducted using the questionnaire KIDSCREEN 27, which was validated in our population and evaluated as recommended by the creators of this instrument.
Results: A total of 24 patients (75%) were men, mean age of 12.1 (SD 2.6) years. 100% of the patients had clinical evaluation and were monitored by Allergology and Ophthalmology, 12 patients (37.5%) were found in mild level, 5 patients (15.6%) were moderate and 14 patients (43.8%) were severe level. The most common symptoms were pruritus (75%), photophobia (50%), lacrimation (37.5%), and secretions (28.1%). 65.6% had a family history of atopy and 84.4% had an allergic comorbidity. Aeroallergen skin tests were found positive in 25 patients (78.1%). All patients had initiated ocular treatment by the time the survey of quality of life was conducted; but, they still had low quality of life scores in the 5 domains assessed. When the scores were evaluated by gender, the only statistically significant difference was found in the domain of family life and free time, which was lower for women.
Conclusion: The vernal keratoconjunctivitis is a disease more prevalent in men. It apparently has an important atopic base in our environment, which due to its severe ocular involvement causes a marked decrease in the quality of life of the children who present it.
References
2. Chenge B, Makumyamviri A, Kaimbo WA, Kaimbo D. Tropical endemic limbo-conjunctivitis in Lúbumbashi. Democratic Republic of the Congo. Bull Soc Belge Ophtalmol. 2003;290:9-16.
3. Jun J, Bielory L, Raizman MB. Vernal conjunctivitis. Immunol Allergy Clin North Am. 2008;28:59-82, vi.
4. Sandford-Smith JH. Vernal eye disease in Northern Nigeria. Trop Geogr Med. 1979;31:321-8.
5. Bonini S, Coassin M, Aronni S, Lambiase A. Vernal keratoconjunctivitis. Eye (Lond). 2004;18:345-51.
6. Diallo JS. Tropical endemic limbo conjunctivitis. Rev Int Trach Pathol Ocul Trop Subtrop. 1976;53:71-80.
7. Rao SK, Meenakshi S, Srinivasan B, Baluswamy S. Perilimbal bulbar conjunctival pigmentation in vernal conjunctivitis: prospective evaluation of a new clinical sign in an Indian population. Cornea. 2004;23:356-9.
8. Bonini S, Bonini S, Lambiase A, Marchi S, Pasqualetti P, Zuccaro O, et al. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term follow-up. Ophthalmology. 2000;107:1157-63.
9. Hu Y, Matsumoto Y, Dogru M, Okada N, Igarashi A, Fukagawa K, et al. The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis. Allergy. 2007;62:917-25.
10. De Smedt S, Wildner G, Kestelyn P. Vernal keratoconjunctivitis: an update. Br J Ophthalmol. 2013;97:9-14.
11. Bonini S, Sacchetti M, Mantelli F, Lambiase A. Clinical grading of vernal keratoconjunctivitis. Curr Opin Allergy Clin Immunol. 2007;7:436-41.
12. Ravens-Sieberer U, Gosch A, Rajmil L, Erhart M, Bruil J, Duer W, et al. KIDSCREEN-52 quality-of-life measure for children and adolescents. Expert Rev Pharmacoecon Outcomes Res. 2005;5:353-64.
13. The KIDSCREEN Group Europe. The KIDSCREEN Questionnaires - quality of life questionnaires for children and adolescents. Handbook. Lengerich: Pabst Science Publishers; 2006.
14. Quintero CA, Lugo AH, García HI, Sánchez A. Validación del cuestionario KIDSCREEN-27 de calidad de vida relacionada con la salud en ninos ˜ y adolescentes de Medellín, Colombia. Rev Colomb Psiquiat. 2011;40:470-87.
15. Ramírez RH, Reina Z, Espinoza Y, Soto ML, Hernández A, Cardona R. Tacrolimus en queratoconjuntivitis vernal. Pediátricas: Alergia, asma e inmunología. 2012;21:5-12.
16. Tesse R, Spadavecchia L, Fanelli P, Rizzo G, Procoli U, Brunetti L, et al. Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children. Pediatr Allergy Immunol. 2010;21 Pt 1:330-5.
17. Leonardi A, Busca F, Motterle L, Cavarzeran F, Fregona IA, Plebani M, et al. Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study. Acta Ophthalmol Scand. 2006;84:406-10.
18. De Smedt S, Nkurikiye J, Fonteyne Y, Hogewoning A, Van Esbroeck M, De Bacquer D, et al. Vernal keratoconjunctivitis in school children in Rwanda and its association with socioeconomic status: a population-based survey. Am J Trop Med Hyg. 2011;85:711-7.
19. Leonardi A, Piliego F, Castegnaro A, Lazzarini D, La Gloria Valerio A, Mattana P, et al. Allergic conjunctivitis: a cross-sectional study. Clin Exp Allergy. 2015;45:1118-25.
20. Fernandes Marback P, De Freitas D, Paranhos AJ, Belfort RJ. Aspectos clínicos e epidemiológicos da conjuntivite alérgica em servic¸o de referência. Arq Bras Oftalmol. 2007;70:312-6.
21. De Oliveira LA, Carvalho Malloz M, Sole D, De Freitas D, De Sousa LB, Mannis MJ. Are cutaneous hypersensitivity tests to inhalant allergens a severity marker for vernal keratoconjunctivitis? Arq Bras Oftalmol. 2007;70:991-5.
22. Ukponmwan CU. Vernal keratoconjunctivitis in Nigerians: 109 consecutive cases. Trop Doct. 2003;33:242-5.
23. Bonini S, Lambiase A, Schiavone M, Centofanti M, Palma LA, Bonini S. Estrogen and progesterone receptors in vernal keratoconjunctivitis. Ophthalmology. 1995;102: 1374-90.
24. Leonardi A, Lazzarini D, Motterle L, Bortolotti M, Deligianni V, Curnow SJ, et al. Vernal keratoconjunctivitis-like disease in adults. Am J Ophthalmol. 2013;155:796-803.
25. Sánchez-Caraballo J, Diez-Zuluaga S, Cardona-Villa R. Sensibilización a aeroalergenos en pacientes alérgicos de Medellín, Colombia. Revista Alergia México. 2012;59: 139-47.
26. López-Piedrahita E, Sánchez-Caraballo J, Ramírez-Giraldo RH, Cardona-Villa R. Efectividad de la inmunoterapia con alérgenos en pacientes con queratoconjuntivitis vernal. Revista Alergia México. 2013;60:11-6.
27. Sacchetti M, Baiardini I, Lambiase A, Aronni S, Fassio O, Gramiccioni C, et al. Development and testing of the quality of life in children with vernal keratoconjunctivitis questionnaire. Am J Ophthalmol. 2007;144:557-63.
28. Yepes-Nunez JJ, Gómez C, Espinoza Y, Cardona R. The impact of subcutaneous immunotherapy with Dermatophagoides farinae and Dermatophagoides pteronyssinus on the quality of life of patients with allergic rhinitis and asthma. Biomedica. 2014;34:282-90.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.